The Long Run with Luke Timmerman
Ein Podcast von Timmerman Report
173 Folgen
-
Ep95: Sue Desmond-Hellmann on Becoming a Biotech Leader
Vom: 26.7.2021 -
Ep94: Jenny Rooke on Investing in Biotech Tools
Vom: 19.7.2021 -
Ep93: Jay Bradner & Andy Plump on Mentoring Young Scientists
Vom: 14.6.2021 -
Ep92: Brad Gray on Spatial Biology
Vom: 1.6.2021 -
Ep91: Daphne Zohar on Biotech Entrepreneurship
Vom: 3.5.2021 -
Ep90: James Sabry on Partnering Amid Scientific Abundance
Vom: 19.4.2021 -
Ep89: Emily Leproust on DNA Synthesis at Scale
Vom: 29.3.2021 -
Ep88: Amy DuRoss on software and logistics for cell and gene therapy
Vom: 15.3.2021 -
Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing
Vom: 1.3.2021 -
Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease
Vom: 9.2.2021 -
Ep85: Luhan Yang on CRISPR Editing for Organ Transplants
Vom: 20.1.2021 -
Ep84: Steve Paul on Treatments for Mental Health
Vom: 22.12.2020 -
Ep83: David Lee on Impact in Pharmaceuticals
Vom: 14.12.2020 -
Ep82: Andrew Farnum on Medicines From Unusual Traits
Vom: 23.11.2020 -
Ep81: Simba Gill on Microbiome Therapies
Vom: 12.11.2020 -
Ep80: Peter Kolchinsky on Pharma's Soul
Vom: 28.10.2020 -
Ep79: Daphne Koller on Machine Learning for Drug Discovery
Vom: 26.10.2020 -
Ep78: Pearl Huang on Exoneural Cancer Biology
Vom: 13.10.2020 -
Ep77: Jennifer Petter on Drugging RNA Targets
Vom: 29.9.2020 -
Ep76: Otello Stampacchia on Becoming a Biotech VC
Vom: 8.9.2020
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
